claim: il-6 : a novel signature associated with covid-19 disease progression and development of anti-sars-cov-2 antibodies
evidence_1: findings il-6 and smadcam expressed as a novel integrative marker (smil index) are associated both with disease-states (early infection and convalescence) as well as development of antiviral humoral responses.", "share smadcam:il-6 (smil index): a novel signature associated with covid-19 disease progression and development of anti-sars-cov-2 antibodies dhanashree jagtap, vikrant m bhor, shilpa bhowmick, nandini kasarpalkar, pooja sagvekar, bhalchandra kulkarni, manish pathak, nirjhar chatterjee, pranam dolas, harsha palav, snehal kaginkar, sharad bhagat, itti munshi, swapneil parikh, sachee agrawal, chandrakant pawar, mala kaneria, smita d mahale, jayanthi shastri, vainav patel medrxiv 2020.10.13.20182949; doi: https://doi.org/10.1101/2020.10.13.20182949 share this article: copy citation tools smadcam:il-6 (smil index): a novel signature associated with covid-19 disease progression and development of anti-sars-cov-2 antibodies dhanashree jagtap, vikrant m bhor, shilpa bhowmick, nandini kasarpalkar, pooja sagvekar, bhalchandra kulkarni, manish pathak, nirjhar chatterjee, pranam dolas, harsha palav, snehal kaginkar, sharad bhagat, itti munshi, swapneil parikh, sachee agrawal, chandrakant pawar, mala kaneria, smita d mahale, jayanthi shastri, vainav patel medrxiv 2020.10.13.20182949; doi: https://doi.org/10.1101/2020.10.13.20182949 "
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )